Crystal Structure of the Neisseria gonorrhoeae MtrD Inner Membrane Multidrug Efflux Pump by Reddy Bolla, Jani et al.
Physics and Astronomy Publications Physics and Astronomy
2014
Crystal Structure of the Neisseria gonorrhoeae
MtrD Inner Membrane Multidrug Efflux Pump
Jani Reddy Bolla
Iowa State University
Chih-Chia Su
Iowa State University, jacksu@iastate.edu
Sylvia V. Do
Iowa State University
Pattathil Radhakrishnan
Iowa State University, abhijith@iastate.edu
Nitin Kumar
Iowa State University
See next page for additional authors
Follow this and additional works at: http://lib.dr.iastate.edu/physastro_pubs
Part of the Biochemistry Commons, Biological and Chemical Physics Commons, Biophysics
Commons, and the Medicinal-Pharmaceutical Chemistry Commons
The complete bibliographic information for this item can be found at http://lib.dr.iastate.edu/physastro_pubs/168. For information on how to cite this
item, please visit http://lib.dr.iastate.edu/howtocite.html.
This Article is brought to you for free and open access by the Physics and Astronomy at Iowa State University Digital Repository. It has been accepted
for inclusion in Physics and Astronomy Publications by an authorized administrator of Iowa State University Digital Repository. For more information,
please contact digirep@iastate.edu.
Crystal Structure of the Neisseria gonorrhoeae MtrD Inner Membrane
Multidrug Efflux Pump
Abstract
Neisseria gonorrhoeae is an obligate human pathogen and the causative agent of the sexually-transmitted
disease gonorrhea. The control of this disease has been compromised by the increasing proportion of
infections due to antibiotic-resistant strains, which are growing at an alarming rate. The MtrCDE tripartite
multidrug efflux pump, belonging to the hydrophobic and amphiphilic efflux resistance-nodulation-cell
division (HAE-RND) family, spans both the inner and outer membranes of N. gonorrhoeae and confers
resistance to a variety of antibiotics and toxic compounds. We here report the crystal structure of the inner
membrane MtrD multidrug efflux pump, which reveals a novel structural feature that is not found in other
RND efflux pumps.
Disciplines
Biochemistry | Biological and Chemical Physics | Biophysics | Medicinal-Pharmaceutical Chemistry
Comments
This article is from PLoS One 9 (2014): 1, doi:10.1371/journal.pone.0097903. Posted with permission.
Rights
© 2014 Bolla et al. This is an open-access article distributed under the terms of the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
Authors
Jani Reddy Bolla, Chih-Chia Su, Sylvia V. Do, Pattathil Radhakrishnan, Nitin Kumar, Feng Long, Tsung-Han
Chou, Jared A. Delmar, Hsiang-Ting Lei, Kanagalaghatta R. Rajashankar, William M. Shafer, and Edward Yu
This article is available at Iowa State University Digital Repository: http://lib.dr.iastate.edu/physastro_pubs/168
Crystal Structure of the Neisseria gonorrhoeae MtrD
Inner Membrane Multidrug Efflux Pump
Jani Reddy Bolla1., Chih-Chia Su2., Sylvia V. Do3., Abhijith Radhakrishnan1, Nitin Kumar1, Feng Long2,
Tsung-Han Chou2, Jared A. Delmar2, Hsiang-Ting Lei1, Kanagalaghatta R. Rajashankar4,
William M. Shafer5,6, Edward W. Yu1,2,3*
1Department of Chemistry, Iowa State University, Ames, Iowa, United States of America, 2Department of Physics and Astronomy, Iowa State University, Ames, Iowa,
United States of America, 3 Bioinformatics and Computational Biology Interdepartmental Graduate Program, Iowa State University, Ames, Iowa, United States of America,
4NE-CAT and Department of Chemistry and Chemical Biology, Cornell University, Argonne National Laboratory, Argonne, Illinois, United States of America, 5Department
of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America, 6 Laboratories of Microbial Pathogenesis, VA Medical
Center, Decatur, Georgia, United States of America
Abstract
Neisseria gonorrhoeae is an obligate human pathogen and the causative agent of the sexually-transmitted disease
gonorrhea. The control of this disease has been compromised by the increasing proportion of infections due to antibiotic-
resistant strains, which are growing at an alarming rate. The MtrCDE tripartite multidrug efflux pump, belonging to the
hydrophobic and amphiphilic efflux resistance-nodulation-cell division (HAE-RND) family, spans both the inner and outer
membranes of N. gonorrhoeae and confers resistance to a variety of antibiotics and toxic compounds. We here report the
crystal structure of the inner membrane MtrD multidrug efflux pump, which reveals a novel structural feature that is not
found in other RND efflux pumps.
Citation: Bolla JR, Su C-C, Do SV, Radhakrishnan A, Kumar N, et al. (2014) Crystal Structure of the Neisseria gonorrhoeae MtrD Inner Membrane Multidrug Efflux
Pump. PLoS ONE 9(6): e97903. doi:10.1371/journal.pone.0097903
Editor: Rajeev Misra, Arizona State University, United States of America
Received January 24, 2014; Accepted April 24, 2014; Published June 5, 2014
Copyright:  2014 Bolla et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health Grants R37AI021150 (W.M.S.) and R01GM086431 (E.W.Y.) and a Veterans Affairs Merit Award
(W.M.S.) from the Medical Research Service of the Department of Veterans Affairs. The Northeastern Collaborative Access Team beamlines of the Advanced
Photon Source is supported by the National Institutes of General Medical Sciences under an award GM103403. Use of the Advanced Photon Source is supported
by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ewyu@iastate.edu
. These authors contributed equally to this work.
Introduction
Neisseria gonorrhoeae is a Gram-negative obligate human patho-
gen. It is the causative agent of the sexually-transmitted disease
gonorrhea and rare cases of disseminated disease. Although
gonorrhea is one of the oldest described diseases, it remains a
significant global problem with more than 100 million cases
reported annually worldwide and antibiotic resistance is a major
concern [1]. The gonococcus employs a number of strategies to
evade host attack. It possesses an intricate mechanism of antigenic
variability through differential expression of the genome and can
easily acquire new genetic material to develop resistance to
antimicrobial agents [1,2]. Gonococci utilize a number of
resistance mechanisms, including antimicrobial inactivation, target
modification and strategies that reduce antimicrobial concentra-
tion, such as reduced permeability of the cell envelope mediated
through alteration of porin proteins and active export of multiple
antimicrobial compounds from the cell by efflux pumps. Among
these different mechanisms, multidrug efflux is considered to be
one of the major causes of failure of drug-based treatments of
infectious diseases, which appears to be increasing in prevalence
[3]. These bacterial multidrug efflux pumps have enormous
clinical consequences. Simultaneously rendering the cell resistant
to multiple structurally-unrelated compounds, their expression
results in bacterial strains resistant to most clinically-relevant
antibiotics [3].
The best characterized and most clinically important of these
multidrug efflux systems in N. gonorrhoeae is the MtrCDE tripartite
efflux pump [4–7]. It is composed of the MtrD inner membrane
transporter, belonging to the HAE-RND protein family [8]; the
MtrC periplasmic protein, a member of the membrane fusion
protein family; and the MtrE integral outer membrane channel
protein. This system provides resistance to a broad spectrum of
antimicrobial agents, including bile salts, fatty acids, dyes,
antibiotics and spermicides. The Mtr multidrug efflux system is
also responsible for resistance to host-derived cationic antimicro-
bial peptides [7], which are important mediators of the innate host
defense. Given that gonococci commonly infect mucosal sites
bathed in fluids containing such peptides, the Mtr system indeed
underscores the pathogenesis of gonococcal disease and its
contribution to virulence. In addition, it has been shown that
the MtrCDE tripartite efflux pump is capable of enhancing long-
term colonization of the mouse vaginal mucosal layer and that
gonococci lacking this efflux pump were highly attenuated [9].
At present, only two crystal structures of HAE-RND-type efflux
pumps are available. These efflux pumps are the Escherichia coli
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AcrB [10–18] and Pseudomonas aeruginosa MexB [19] multidrug
transporters. Their structures suggest that both AcrB and MexB
span the entire width of the inner membrane and protrude
approximately 70 A˚ into the periplasm. Along with the models of
these two HAE-RND transporters, the crystal structures of the
other components of these tripartite complex systems have also
been determined. These include the outer membrane channels E.
coli TolC [20] and P. aeruginosa OprM [21], as well as the
periplasmic membrane fusion proteins E. coli AcrA [22] and P.
aeruginosa MexA [23–25].
Currently, no structural information is available for any protein
component of the MtrCDE tripartite complex system. To
elucidate the mechanism used by this efflux system for multidrug
recognition and extrusion, we here describe the crystal structure of
the inner membrane MtrD multidrug efflux pump. The findings
reveal a novel structural feature that is not found in other known
RND efflux pumps.
Results and Discussion
Overall Structure of the N. gonorrhoeae MtrD Multidrug
Efflux Pump
We cloned, expressed and purified the full-length MtrD efflux
pump containing a 6xHis tag at the C-terminus. We obtained
crystals of this membrane protein following an extensive screening
for crystallization conditions with different detergents. We then
used molecular replacement, utilizing the structure of the ‘‘access’’
protomer of AcrB (pdb code: 2DHH) [12] to determine the three-
dimensional structure. The diffraction data can be indexed to the
space group R32. Data collection and refinement statistics are
summarized in Table 1. The resulting electron density maps
(Fig. 1) reveal that the asymmetric unit consists of one protomer.
The crystal structure of the MtrD multidrug efflux pump has been
determined to a resolution of 3.53 A˚ (Table 1). Currently, 97% of
the amino acids (residues 2–493 and 508–1040) are included in the
final model (Fig. 2a). The final structure is refined to Rwork and
Rfree of 27.9% and 33.3%, respectively. The structure of MtrD is
closer to the conformation of the ‘‘access’’ protomer of AcrB.
However, superimposition of these two structures results in a high
RMSD of 7.6 A˚ over 1,000 Ca atoms, suggesting that there are
significant differences between these two transporters (Fig. S1).
MtrD assembles as a 125-A˚ long and 95-A˚ wide homotrimer
(Fig. 2b). Each protomer comprises 12 transmembrane helices
(TM1–TM12). Like other RND transporters, the N-terminal
(TM1–TM6) and C-terminal (TM7–TM12) halves of MtrD are
related by a pseudo-twofold symmetry. A large periplasmic
domain is created by two extensive periplasmic loops connecting
TM1 with TM2 and TM7 with TM8, respectively. As in AcrB
[10–18] and MexB [19], this periplasmic domain can be divided
into six sub-domains: PN1, PN2, PC1, PC2, DN and DC (Figs. 2
and 3). Sub-domains PN1, PN2, PC1 and PC2 form the pore
domain, with PN1 making up the central pore and stabilizing the
trimeric organization. However, sub-domains DN and DC
contribute to form the docking domain, presumably interacting
with the outer membrane channel MtrE. The trimeric MtrD
structure suggests that sub-domains PN2, PC1 and PC2 are
located at the outermost core of the periplasmic domain, facing the
periplasm. Sub-domains PC1 and PC2 also form an external cleft,
and this cleft is open in the MtrD structure (Fig. 2). Based on the
co-crystal structure of CusBA [26,27] of the CusCBA tripartite
efflux system [28–33], the upper regions of PN2, PC1, PC2 and
sub-domains DN and DC should directly interact with the MtrC
membrane fusion protein to form a functional adaptor-transporter
complex.
The N. gonorrhoeae MtrCDE tripartite efflux system has the
advantage that all these protein components are encoded by the
same operon. Thus, the interactions between different proteins are
likely to be specific, facilitating analyses of how different
components function cooperatively.
Periplasmic Multidrug Binding Site
Crystallization of AcrB with a variety of substrates [12,16–18]
has identified that the periplasmic cleft of the pump forms several
mini-binding pockets within the extensive, large periplasmic
multidrug binding site. This site is supposed to play a predominant
role in the selection of drugs for export. Protein sequence
alignment reveals that many of the amino acids forming the large
periplasmic binding site of AcrB are conserved among MexB and
MtrD, indicating that these three multidrug efflux pumps may
have a similar substrate binding profile for drug recognition. These
conserved amino acids in MtrD include several charged and polar
residues, such as S79, S134, R174, D272, E669 and R714, and
aromatic residues, such as F136, F176, F610, F612 and F623
(Fig. 3).
A flexible loop is found inside the large periplasmic cleft (Fig.
S1), which form the multidrug binding site of the pump. This
flexible loop is located deep inside the cleft between subdomains
PC1 and PC2, composed of residues 608–619, and should
correspond to the Phe-617 loop [16] in AcrB. The loop is highly
conserved among MtrD, AcrB and MexB. It is expected that this
flexible loop is important for drug recognition and extrusion.
There is a chance that this loop may shift positions during the
course of the extrusion process to facilitate drug export.
Transmembrane Helix TM9
Perhaps the most interesting secondary structural feature
appears in TM9 of the MtrD pump. In contrast to other known
structures of the RND transporters, MtrD contains an extended
region that protrudes into the periplasm and contributes part of
the periplasmic domain (Figs. 2 and 3). This region (residues 917–
927) comprises an a-helix extending from the upper portion of
TM9 and also to the loop connecting TM9 and TM10. Protein
sequence alignment suggests that these extra residues are only
found in MtrD and not other homologous RND proteins.
Therefore, this fragment should represent a unique feature of this
pump that cannot be found in other RND pumps. TM9 is distinct
in that it is not vertically oriented. Instead, it is inclined from the
horizontal membrane plane by 54u. The spatial arrangement
between the extra elongated helix and loop (upper portion of
TM9) and the periplasmic cleft formed between PC1 and PC2
suggests that these extra structural features may help the pump to
transport its substrates more effectively from the outer leaflet of the
inner membrane to the multidrug binding site at the periplasmic
domain (Fig. 4).
Proton-relay Network
Drug export by RND transporters is proton motive force
(PMF)-dependent. Based on the crystal structure of MtrD, it is
expected that the charged residues D405 and D406 of TM4 and
K948 of TM10 are important for forming the proton-relay
network of the pump (Fig. 5). These residues are supposed to
undergo protonation and deprotonation within the transport cycle.
The involvement of these charged amino acids in proton
translocation was supported by a previous study that showed
mutations of these residues inhibits proton translocation [34]. In
turn, the MtrE outer membrane channel protein is blocked and
unable to dissociate from the MtrCDE tripartite efflux complex
[34].
Structure of the N. gonorrhoeae MtrD Efflux Pump
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Figure 1. Stereo view of the electron density map of the MtrD efflux pump at a resolution of 3.53 A˚. (a) The electron density map
contoured at 1.2 s is in blue. The Ca traces of MtrD are in red. (b) Representative section of the electron density at the interface between TM11 and
TM12 of MtrD. The electron density (colored white) is contoured at the 1.2 s level and superimposed with the final refined model (green, carbon; red,
oxygen; blue, nitrogen).
doi:10.1371/journal.pone.0097903.g001
Structure of the N. gonorrhoeae MtrD Efflux Pump
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Table 1. Data collection and refinement statistics.
Data set MtrD
Data Collection
Wavelength (A˚) 0.98
Space group R32
Resolution (A˚) 50–3.53
(3.68–3.53)
Cell constants (A˚)
a 152.99
b 152.95
c 360.74
a, b, c (u) 90, 90, 120
Molecules in ASU 1
Redundancy 2.9 (2.9)
Total reflections 377,955
Unique reflections 20,296
Completeness (%) 97.7 (98.0)
Rsym (%) 7.7 (42.9)
I/s(I) 17.16 (1.9)
Refinement
Resolution (A˚) 50–3.53
Rwork 27.9
Rfree 33.3
rms deviation from ideal
bond lengths (A˚) 0.003
bond angles (u) 0.794
Ramachandran
most favoured (%) 89.6
additional allowed (%) 10.1
generously allowed (%) 0.3
disallowed (%) 0
doi:10.1371/journal.pone.0097903.t001
Figure 2. Structure of the N. gonorrhoeae MtrD efflux pump. (a) Ribbon diagram of a protomer of MtrD viewed in the membrane plane. The
molecule is colored using a rainbow gradient from the N-terminus (blue) to the C-terminus (red). Sub-domains DN, DC, PN2, PC1 and PC2 are labeled.
The location of PN1 is behind PN2, PC1 and PC2. (b) Ribbon diagram of the MtrD trimer viewed in the membrane plane. Each subunit of MtrD is
labeled with a different color. Residues 917–927 (only found in MtrD) forming the upper portion of TM9 and the loop connecting TM9 and TM10 are
in blue color.
doi:10.1371/journal.pone.0097903.g002
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The MtrD multidrug efflux pump should operate through an
alternating-access mechanism, similar to the AcrB transporter.
Thus, the pump has to go through the transport cycle, which
should involve different transient conformations, including the
‘‘access’’, ‘‘binding’’ and ‘‘extrusion’’ states of this protein. In the
MtrD trimer, the conformations of the three protomers are
identical to each other, suggesting that these protomers represent
the same transient state. In comparison with the structures of
AcrB, the conformation of MtrD is closer to that of the ‘‘access’’
protomer of AcrB (Fig. S1). Therefore, our MtrD structure should
represent the ‘‘access’’ transient state of the pump. It is expected
that this pump will change in conformation to go through the
Figure 3. Sequence and topology of MtrD, AcrB and MexB. Alignment of the amino acid sequences of MtrD, AcrB and MexB were done using
CLUSTAL W (*, identical residues; :, .60% homologous residues). Secondary structural elements are indicated: TM, transmembrane helix; Na and Nb,
helix and strand, respectively, in the N-terminal half; Ca and Cb, helix and strand, respectively, in the C-terminal half. The MtrE docking domain is
divided into two sub-domains, DN and DC; whereas the pore domain is divided into four sub-domains, PN1, PN2, PC1 and PC2. The sequence and
topology of MtrD are shown at the top.
doi:10.1371/journal.pone.0097903.g003
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Figure 4. Spatial arrangement between TM9 and the periplasmic cleft. TM9 is inclined from the horizontal membrane plane by 54u. The
extra feature (yellow), which is only found in the MtrD pump within the family, is located right next the cleft formed by subdomains PC1 and PC2.
doi:10.1371/journal.pone.0097903.g004
Figure 5. Ion pairs in the transmembrane domain viewed from the cytoplasmic side. Residues D405 and D406 of TM4 and K948 of TM10
that form ion pairs, which may play an important role in proton translocation, are in green sticks.
doi:10.1371/journal.pone.0097903.g005
Structure of the N. gonorrhoeae MtrD Efflux Pump
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cycle. This conformational change should be coupled to the PMF
initiated by the proton-relay network.
Methods
Cloning, Expression and Purification of the Inner
Membrane MtrD Efflux Pump
Briefly, the full-length MtrD membrane protein containing a
6xHis tag at the C-terminus was overproduced in E. coli
C43(DE3)DacrB cells, which harbor a deletion in the chromosomal
acrB gene, possessing pET15bVmtrD. Cells were grown in 12 L of
2xYT medium with 100 mg/ml ampicillin at 25uC. When the
OD600 reached 0.6, the culture was treated with 1 mM IPTG to
induce mtrD expression, and cells were harvested within 15 h. The
collected bacteria were resuspended in low salt buffer containing
100 mM sodium phosphate (pH 7.2), 10% glycerol, 1 mM
ethylenediaminetetraacetic acid (EDTA) and 1 mM phenylmetha-
nesulfonyl fluoride (PMSF), and then disrupted with a French
pressure cell. The membrane fraction was collected and washed
twice with high salt buffer containing 20 mM sodium phosphate
(pH 7.2), 2 M KCl, 10% glycerol, 1 mM EDTA and 1 mM
PMSF, and once with 20 mM HEPES-NaOH buffer (pH 7.5)
containing 1 mM PMSF. The membrane protein was then
solubilized in 2% (w/v) 6-cyclohexyl-1-hexyl-b-D-maltoside
(Cymal-6). Insoluble material was removed by ultracentrifugation
at 100,0006g. The extracted protein was purified with a Ni2+-
affinity column. The purity of the MtrD protein (.95%) was
judged using 10% SDS-PAGE stained with Coomassie Brilliant
Blue. The purified protein was then dialyzed and concentrated to
20 mg/ml in a buffer containing 20 mM Na-HEPES (pH 7.5) and
0.05% Cymal-6.
Crystallization of MtrD
Crystals of the 6xHis MtrD were obtained using sitting-drop
vapor diffusion. The MtrD crystals were grown at room
temperature in 24-well plates with the following procedures. A
2 ml protein solution containing 20 mg/ml MtrD protein in
20 mM Na-HEPES (pH 7.5) and 0.05% (w/v) Cymal-6 was mixed
with a 2 ml of reservoir solution containing 30% PEG 400, 0.1 M
Na-Bicine (pH 8.5), 0.1 M NH4Cl, 0.05 M BaCl2 and 9%
glycerol. The resultant mixture was equilibrated against 500 ml
of the reservoir solution. Crystals of MtrD grew to a full size in the
drops within a week. Typically, the dimensions of the crystals were
0.2 mm60.2 mm60.2 mm. The crystals were flash-cooled, using
solution containing 40% PEG 400, 0.1 M Na-Bicine (pH 8.5),
0.1 M NH4Cl, 0.05 M BaCl2, 9% glycerol and 0.05% Cymal-6 as
a cryoprotectant before data collection.
Data Collection, Structural Determination and
Refinement
All diffraction data were collected at 100 K at beamline 24ID-C
located at the Advanced Photon Source, using an ADSC
Quantum 315 CCD-based detector. Diffraction data were
processed using DENZO and scaled using SCALEPACK [35].
Crystals of the MtrD efflux pump belong to the space group R32
(Table 1) and the best crystal diffracted x-ray to a resolution of
3.53 A˚. Analysis of Matthew’s coefficient indicated the presence of
one MtrD protomer (113.69 kDa) per asymmetric unit, with a
solvent content of 66.7%.
The structure of MtrD was phased using molecular replace-
ment, utilizing the structure of the ‘‘access’’ protomer of AcrB (pdb
id: 2DHH) [12] as a search model. After tracing the initial model
manually using the program Coot [36], the model was refined
against the native data at 3.53 A˚-resolution using TLS refinement
techniques adopting a single TLS body as implemented in
PHENIX [37] leaving 5% of reflections in Free-R set. Iterations
of refinement using PHENIX [37] and CNS [38] and model
building in Coot [36] lead to the current model, which consists of
1,025 residues with excellent geometrical characteristics (Table 1).
Accession Code
Atomic coordinates and structure factors have been deposited in
the Protein Data Bank with accession code 4MT1.
Supporting Information
Figure S1 Comparison of the structures of the MtrD
and AcrB efflux pumps. (a) Ribbon diagram of protomers of
MtrD and AcrB viewed in the membrane plane. This is a
superimposition of a subunit of MtrD (red) onto an ‘‘access’’
protomer of AcrB (pdb: 2DHH) (green), indicating that the
structures of these two efflux pumps are quite distinct. Superim-
position of these two structures result in a high RMSDs of 7.6 A˚
over 1,000 Ca atoms. (b) Front view of the periplasmic clefts,
formed by subdomains PC1 and PC2, of MtrD and AcrB. The
secondary structural elements of these two transporters are colored
red (MtrD) and green (AcrB). (c) Potential multidrug binding
within the periplasmic cleft of MtrD. The flexible loop created by
residues 608–619 is colored blue. This loop should correspond to
the Phe-617 loop in AcrB. It is suspected that this flexible loop
may swing into this drug binding site to facilitate export during
drug extrusion. The rest of the secondary structural elements of
MtrD are colored red.
(TIF)
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